Gu Shenyan, Wang Yuqin, Ke Kaifu, Tong Xin, Gu Jiahui, Zhang Yuanyuan
Department of Neurology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Department of Neurology, Affiliated Hospital of Nantong University, Nantong, China.
Curr Med Res Opin. 2022 Nov;38(11):1923-1933. doi: 10.1080/03007995.2022.2113690. Epub 2022 Aug 25.
Richmond agitation-sedation scale (RASS) is a simple and widely used tool for evaluating sedation and agitation in adult ICU patients. Early deep sedation has been shown to be an important independent predictor of death, however, studies on the role of RASS in the prognostic assessment of neurocritical patients are lacking. The purpose of this study was to investigate the relationship between RASS and in-hospital mortality in neurocritical patients, and to develop and validate an effective predictive model based on this.
This was a retrospective study of neurocritical patients from a large clinical database. A total of 2651 patients were collected, including general demographic characteristics, past medical history, biochemical test data and physical examination within 24 h of admission, and related medical records. Univariate and multivariate logistic regression analyses were used to screen out significant variables. Finally, 11 significant predictors were included into the logistic regression to establish the nomogram.
The area under the curve (AUC) of the nomogram was 0.9087(0.8950-0.9224) and the corrected c index was 0.9043, which gave the model better discriminatory ability compared with critical care related scales, such as SOFA and SAPSII scores. Besides, tools including calibration curve, decision curve analysis (DCA), and clinical impact curve (CIC) were used to verify that the model had good discrimination, calibration, and clinical applicability.
RASS score was an independent prognostic predictor of in-hospital death in neurocritical patients, and patients who are deeply sedated have a worse prognosis. RASS-related nomogram could be applied to predict the prognosis of neurocritical patients and to take effective intervention measures in early stage.
里士满躁动镇静评分(RASS)是一种用于评估成年重症监护病房(ICU)患者镇静和躁动情况的简单且广泛使用的工具。早期深度镇静已被证明是死亡的重要独立预测因素,然而,关于RASS在神经重症患者预后评估中的作用的研究尚缺乏。本研究的目的是探讨RASS与神经重症患者院内死亡率之间的关系,并基于此开发和验证一个有效的预测模型。
这是一项对来自大型临床数据库的神经重症患者的回顾性研究。共收集了2651例患者,包括一般人口统计学特征、既往病史、入院24小时内的生化检验数据和体格检查以及相关医疗记录。采用单因素和多因素逻辑回归分析筛选出显著变量。最后,将11个显著预测因素纳入逻辑回归以建立列线图。
列线图的曲线下面积(AUC)为0.9087(0.8950 - 0.9224),校正后的c指数为0.9043,与重症监护相关量表如序贯器官衰竭评估(SOFA)和简化急性生理学评分(SAPSII)相比,该模型具有更好的辨别能力。此外,使用包括校准曲线、决策曲线分析(DCA)和临床影响曲线(CIC)在内的工具来验证该模型具有良好的辨别力、校准度和临床适用性。
RASS评分是神经重症患者院内死亡的独立预后预测因素,深度镇静的患者预后较差。与RASS相关的列线图可用于预测神经重症患者的预后并在早期采取有效的干预措施。